FY2022 · ended Mar 31, 2023 · Revenue $276,324 · Filed Feb 19, 2025
Avai Bio, Inc. (AVAI) files with the SEC under industry code 7374, Services-Computer Processing & Data Preparation.
Revenue
$276,324
Net income
$-1.75M
-53.2% vs prior year
Operating cash flow (TTM)
$-1.18M
+14.7% vs year-ago TTM
Free cash flow
—
EPS
—
Dividend per share
$0.03
Shares outstanding
153.92M
+11.9% vs prior year
Net cash
$-1,773
FY 2026
Operating margin
-126.3%
FY 2022
Company profile
- Industry
- Services-Computer Processing & Data Preparation (SIC 7374)
- Listed as
- AVAI (OTC)
- Fiscal year ends
- March 31
- Incorporated in
- NV
- Headquarters
- Las Vegas, NV
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1740797
- Former names
- AVANT TECHNOLOGIES INC. (until Feb 9, 2026); TREND INNOVATIONS HOLDING INC. (until Jul 19, 2023); FREECOOK (until Jun 5, 2020)
Other Services-Computer Processing & Data Preparation companies
- Automatic Data Processing Inc ADP
- Workday, Inc. WDAY
- Verisk Analytics, Inc. VRSK
- Toast, Inc. TOST
- Reddit, Inc. RDDT
- Hinge Health, Inc. HNGE
- RingCentral, Inc. RNG
- Pegasystems Inc PEGA
All 110 Services-Computer Processing & Data Preparation companies
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2026 Mar 31, 2026 |
FY 2025 Mar 31, 2025 |
FY 2024 Mar 31, 2024 |
FY 2022 Mar 31, 2023 |
FY 2021 Mar 31, 2021 |
|---|---|---|---|---|---|
| Revenue | — | — | — | $276,324 | — |
| Operating income | -$1.7M | -$1.1M | -$2.1M | -$348,933 | $302,292 |
| Net income | -$1.7M | -$1.1M | -$2.1M | -$348,933 | -$302,292 |
| Operating cash flow | -$1.0M | -$1.2M | -$1.3M | -$54,457 | $23,090 |
| Total assets | $572,696 | $224,745 | $322,014 | $241,460 | $816,269 |
| Total liabilities | $3.4M | $1.8M | $1.8M | $874,719 | — |
| Stockholders' equity | -$2.8M | -$1.6M | -$1.5M | -$633,259 | -$327,413 |
| Cash and investments | $23,145 | $81,053 | $281 | $107,472 | $60,364 |
| Total debt | $24,918 | $112,520 | — | $99,000 | — |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Aug 13, 2026 | Jun 30, 2026 |
| 10-K | Annual report | Jul 14, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Material agreement
|
May 8, 2026 | May 7, 2026 |
| 10-Q | Quarterly report | Feb 12, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Other events
|
Feb 9, 2026 | Feb 3, 2026 |
| 10-Q | Quarterly report | Nov 14, 2025 | Sep 30, 2025 |
All 117 Avai Bio, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.